Overview

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Status:
Active, not recruiting

Trial end date:
2020-06-01

Target enrollment:

Participant gender:

Summary

Compare the efficacy and safety of Bromhexine Hydrochloride Tablets combined with standard treatment/ standard treatment in patients with suspected and mild, or common novel coronavirus pneumonia (COVID-19). Random, open, group sequential design.

Phase:

N/A

Details

Lead Sponsor:

Second Affiliated Hospital of Wenzhou Medical University

Collaborators:

Wanbangde Pharmaceutical Group Co., LTD
WanBangDe Pharmaceutical Group Co.,Ltd.

Treatments:

Bromhexine
Interferons